These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9934781)

  • 21. Improved detection of second primary cancer using integrated [18F] fluorodeoxyglucose positron emission tomography and computed tomography for initial tumor staging.
    Choi JY; Lee KS; Kwon OJ; Shim YM; Baek CH; Park K; Lee KH; Kim BT
    J Clin Oncol; 2005 Oct; 23(30):7654-9. PubMed ID: 16234527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Established, emerging and future roles of PET/CT in the management of colorectal cancer.
    Herbertson RA; Scarsbrook AF; Lee ST; Tebbutt N; Scott AM
    Clin Radiol; 2009 Mar; 64(3):225-37. PubMed ID: 19185652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical impact of fluorodeoxyglucose-positron emission tomography scan/computed tomography in comparison with computed tomography on the detection of colorectal cancer recurrence.
    Deleau C; Buecher B; Rousseau C; Kraeber-Bodéré F; Flamant M; des Varannes SB; Frampas E; Galmiche JP; Matysiak-Budnik T
    Eur J Gastroenterol Hepatol; 2011 Mar; 23(3):275-81. PubMed ID: 21304319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PET and PET-CT for evaluation of colorectal carcinoma.
    Delbeke D; Martin WH
    Semin Nucl Med; 2004 Jul; 34(3):209-23. PubMed ID: 15202102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positron emission tomography scanning is not superior to whole body multidetector helical computed tomography in the preoperative staging of colorectal cancer.
    Furukawa H; Ikuma H; Seki A; Yokoe K; Yuen S; Aramaki T; Yamagushi S
    Gut; 2006 Jul; 55(7):1007-11. PubMed ID: 16361308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Value of 18F-fluoro-2-deoxyglucose positron emission tomography in the evaluation of recurrent colorectal cancer.
    Hung GU; Shiau YC; Tsai SC; Chao TH; Ho YJ; Kao CH
    Anticancer Res; 2001; 21(2B):1375-8. PubMed ID: 11396217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [PET/CT in colorectal cancer].
    Talbot JN
    Rev Prat; 2010 Oct; 60(8):1074-7. PubMed ID: 21197736
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical value of whole-body positron emission tomography with [18F]fluorodeoxyglucose in recurrent colorectal cancer.
    Beets G; Penninckx F; Schiepers C; Filez L; Mortelmans L; Kerremans R; Aerts R; De Roo M
    Br J Surg; 1994 Nov; 81(11):1666-70. PubMed ID: 7827902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimizing the role of FDG PET-CT for potentially operable metastatic colorectal cancer.
    Culverwell AD; Chowdhury FU; Scarsbrook AF
    Abdom Imaging; 2012 Dec; 37(6):1021-31. PubMed ID: 22371087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [18F]Fluorodeoxyglucose PET/Computed Tomography in Gastrointestinal Malignancies.
    Donswijk ML; Hess S; Mulders T; Lam MG
    PET Clin; 2014 Oct; 9(4):421-41, v-vi. PubMed ID: 26050945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FDG-PET for the pre-operative evaluation of colorectal liver metastases.
    Arulampalam TH; Francis DL; Visvikis D; Taylor I; Ell PJ
    Eur J Surg Oncol; 2004 Apr; 30(3):286-91. PubMed ID: 15028310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FDG-PET improves the staging and selection of patients with recurrent colorectal cancer.
    Lonneux M; Reffad AM; Detry R; Kartheuser A; Gigot JF; Pauwels S
    Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):915-21. PubMed ID: 12111132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of 18 F-fluorodeoxyglucose positron emission tomography and computed tomography with histopathologic correlation in the initial staging of head and neck cancer.
    Hannah A; Scott AM; Tochon-Danguy H; Chan JG; Akhurst T; Berlangieri S; Price D; Smith GJ; Schelleman T; McKay WJ; Sizeland A
    Ann Surg; 2002 Aug; 236(2):208-17. PubMed ID: 12170026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can (18)F-FDG PET/CT scan change treatment planning and be prognostic in recurrent colorectal carcinoma? A prospective and follow-up study.
    Artiko V; Odalovic S; Sobic-Saranovic D; Petrovic M; Stojiljkovic M; Petrovic N; Kozarevic N; Grozdic-Milojevic I; Obradovic V
    Hell J Nucl Med; 2015; 18(1):35-41. PubMed ID: 25840571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new imaging technique for colorectal cancer: positron emission tomography.
    Flamen P; Van Cutsem E; Mortelmans L
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):22-9. PubMed ID: 11049029
    [No Abstract]   [Full Text] [Related]  

  • 36. [Positron emission tomography for the preoperative staging of esophageal carcinoma].
    Junginger T; Kneist W; Schreckenberger M; Menzel C; Oberholzer K; Bartenstein P
    Dtsch Med Wochenschr; 2002 Sep; 127(38):1935-41. PubMed ID: 12239652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility of 18-fluorodeoxyglucose positron emission/computed tomography in the management of recurrent colorectal cancer.
    Liong SY; Kochhar R; Renehan AG; Manoharan P
    ANZ J Surg; 2012 Oct; 82(10):729-36. PubMed ID: 22989147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. F-18 fluorodeoxyglucose positron emission tomography in the non-invasive staging of non-small cell lung cancer.
    Berlangieri SU; Scott AM; Knight SR; Fitt GJ; Hennessy OF; Tochon-Danguy HJ; Clarke CP; McKay WJ
    Eur J Cardiothorac Surg; 1999 Sep; 16 Suppl 1():S25-30. PubMed ID: 10536941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology.
    Antoch G; Vogt FM; Freudenberg LS; Nazaradeh F; Goehde SC; Barkhausen J; Dahmen G; Bockisch A; Debatin JF; Ruehm SG
    JAMA; 2003 Dec; 290(24):3199-206. PubMed ID: 14693872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of positron emission tomography with fluorine-18-deoxyglucose in identifying colorectal cancer metastases to liver.
    Zhuang H; Sinha P; Pourdehnad M; Duarte PS; Yamamoto AJ; Alavi A
    Nucl Med Commun; 2000 Sep; 21(9):793-8. PubMed ID: 11065150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.